查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2123813

全球乳房X光檢查市場：市場結構、預測、競爭趨勢與人工智慧貨幣化架構（2024-2035年）

Global Mammography Horizon Report: Market Structure, Forecasts, Competitive Dynamics, and AI Monetization Architecture, 2024A-2035F
出版日期: | 出版商: Marketstrat, Inc. | 英文 321 Pages | 訂單完成後即時交付

價格

報告摘要

儘管乳房X光攝影仍然是醫學影像領域最成熟的篩檢基礎設施市場之一，但將其簡單地視為設備更換類別已不再合適。專用乳房X光攝影系統、數位乳房斷層合成（DBT）、支援複合電子顯微鏡（CEM）的機架、服務合約、乳房X光攝影專用工作流程軟體、人工智慧、乳房切片、行動篩檢和輔助影像路徑等，正日益透過同一商業性決策鏈相互關聯。

本報告分析了2024年（預估）至2035年（預測）的全球乳房X光攝影市場及更廣泛的乳房攝影影像生態系統。報告區分了「核心乳房X光乳房X光攝影市場」與「介入性乳房治療路徑」以及更廣泛的「乳房攝影生態系統機會」，使讀者能夠清晰地區分關鍵系統和服務的基礎組成部分，以及涵蓋相關手術、超音波、磁振造影、診療管道和工作流程的價值池。

核心商業問題不再只是「誰銷售乳房X光機機架」，而是「誰控制著圍繞機架的乳房攝影操作系統——包括更換時間、服務、人工智慧、臨床增強顯微鏡（CEM）、切片檢查、企業工作流程、供應商經濟效益、行動存取以及輔助成像路徑」。本報告的競爭要點在於，持續佔主導地位的關鍵在於從機架市場佔有率轉向控制平面市場佔有率。

本報告是Marketstrat對全球乳房X光攝影和乳房攝影影像市場結構進行的詳細分析。報告針對醫療影像設備OEM廠商高階主管、乳房健康策略團隊、人工智慧和工作流程供應商、企業影像平台、乳房介入技術公司、投資者、私募股權公司、經銷商、醫療服務提供者網路以及公共部門影像領導者。

本報告涵蓋篩檢和診斷性乳房X光攝影、全視野數位乳房X光攝影（FFDM）、造影乳房X光攝影、乳房X光攝影專用軟體和工作站、乳房人工智慧、密度和風險評估工具、服務合約、行動篩檢、影像導引乳房介入治療以及補充性乳房攝影影像路徑。報告還評估了成熟續保市場、准入擴展市場、篩檢專案市場、中國雙通路採購結構以及高階私人醫療網路中的乳房攝影路徑的價值轉移。

本報告旨在回答以下實際商業問題：

  • 現在，隨著機架硬體的成熟，乳房X光攝影技術在哪些領域仍在發展？
  • 核心乳房X光攝影市場的價值來源是什麼？鄰近乳房攝影診斷路徑的價值來源又是什麼？
  • 如果醫療機構的總價值可能超過供應商累計的軟體收入，供應商應該如何實現其人工智慧的利潤？
  • 哪些產業與CEM的商業性相關性最高？
  • 哪些公司在已部署設備、服務、切片檢查流程、企業工作流程、人工智慧層、醫療保健檢測量以及中國/價值級管道方面佔市場主導地位？
  • 美國、歐洲、中國、日本、印度、拉丁美洲以及中東和非洲（MEA）的區域戰略有何不同？

市場概覽

儘管全球乳房X光檢查市場結構已趨於成熟，但其策略發展依然活躍。機架式設備部署仍是市場的基礎，但最重要的成長和競爭發展都圍繞著機架式設備。具體而言，這些發展包括人工智慧/工作流程軟體、基於電腦輔助診斷（CEM）的診斷流程、服務維護、乳房介入手術、乳房超音波（MRI）、行動接入基礎設施以及基於風險的篩檢。

本報告中的市場結構分為以下三個層次：

核心乳房X光攝影市場

專用乳房X光攝影系統、專用乳房X光攝影服務、專用乳房X光攝影軟體/工作站及乳房X光攝影人工智慧/工作流程。

乳腺介入治療途徑

切片檢查系統、定位、影像導引介入治療及相關後續手術的經濟分析。

乳房攝影影像生態系中的機遇

除了核心的乳房X光攝影市場外，這還包括乳房介入治療途徑和乳房超音波/MRI等相關領域。

這一點至關重要，因為即使是成長停滯或緩慢成長的龍門架市場，也能推動一個規模更大、變化更快的生態系統的發展。根據本報告的框架分析，雖然設備和服務構成了一個穩定的市場，佔了大部分部署佔有率，但人工智慧/工作流程、CEM、乳房超音波、乳房MRI以及切片檢查/介入治療正在推動更廣泛的策略機會。

主要市場趨勢

1.乳房X光攝影正在從硬體升級轉向生態系統主導。

  • 最強大的競爭對手並非僅僅是擁有最多掃描架的公司，而是那些能夠獲得續約項目、增加服務、整合人工智慧和工作流程、實現臨床事件管理、支援切片檢查流程，並將乳房攝影影像保留在自身營運環境中的公司。

2. DBT 正成為已開發國家市場的標準配備。

  • 儘管數位乳房斷層合成（DBT）仍然具有重要的戰略意義，但在許多已開發市場，它正日益被視為一種更新換代產品或高階標準配置，而非由新市場開發驅動的成長點。未來的差異化因素正在轉向工作流程、患者體驗、人工智慧整合、CEM相容性、輻射計量、掃描速度、服務以及儀器套件的經濟性。

3. CEM 是短期內最重要的高階技術附加功能。

  • 雖然造影乳房X光攝影尚未成為廣泛篩檢的標準方法，但它對於詳細檢查緻密型乳房、應對診斷難題、提供特定的MRI替代方案、開展增強乳房X光切片檢查引導下的活體組織切片以及確立高階乳房中心的地位都具有重要的戰略意義。本報告將增強乳房X光攝影視為實用且短期的輔助手段，而非遙遠的尖端技術。

4. 人工智慧的貨幣化需要與醫療機構的經濟考量分開考慮。

  • 本報告區分了供應商的AI/工作流程淨收入和醫療服務提供者的總收入。供應商收入包括軟體、OEM捆綁式AI、SaaS、企業訂閱和單次測試費用。醫療服務提供者的總收入包括額外的病患自付費用、工作流程效率提升、複檢管理、保險報銷和下游處理能力。這種區分避免了重複累計，並明確了價值的受益者。

5. 乳房超音波和乳房核磁共振成像不屬於核心分母，但它們在商業性很重要。

  • 輔助影像技術在乳房攝影影像檢查流程中發揮核心作用。雖然乳房超音波和乳房磁振造影被視為相關領域，而非乳房X光攝影的核心收入來源，但它們對診斷後的追蹤、緻密型乳房的診療流程、高風險患者的管理、醫療機構的收入結構以及供應商生態系統策略都具有顯著影響。

6. 區域戰略不是單一的全球進入曲線。

  • 本報告將乳房X光檢查定位為一個具有全球平台經濟的區域政策和採購市場。其實施受到目標年齡層、公共專案設計、保險覆蓋範圍、採購系統、人力資源限制、醫療保健網路結構以及區域服務能力等因素的影響。

競爭格局

Marketstrat 將乳房X光攝影市場分為八個競爭叢集，因為該市場越來越受到控制平面的影響，而不是簡單的OEM排名。

本報告分析以下幾點：

  • 現有系統 OEM/乳房健康平台公司：Hologic、GE HealthCare、西門子醫療、富士膠片、佳能醫療、Planmed、IMS/Giotto 以及部分區域專業公司。
  • 中國及低價位挑戰者：聯影、萬東、邁瑞、東軟、Inkon 以及區域經銷商。
  • 乳房 AI 檢測及第二領先供應商：ScreenPoint、Lunit、DeepHealth/iCAD、Hologic Genius AI、Vara、Therapixel、CureMetrix 及相關篩檢AI 資產。
  • 用於密度、風險和人口健康管理的 AI 平台：Lunit/Volpara、Clairity、Densitas、b-rayZ、ScreenPoint/Biomediq 和 DeepHealth。
  • 企業影像診斷、乳房工作流程與 AI編配平台：Visage/Pro Medicus、Sectra、Fujifilm Synapse、Intelerad、GE、Siemens、Philips、Mach7、Agfa、Hyland 及相關平台。
  • 乳房介入治療路徑及切片檢查生態系：Hologic、Mammotome、BD、Merit Medical、Leica/Danaher、GE、Siemens 及相關手術設備。
  • 醫療保健提供者網路、行動存取和遠端乳房X光檢查提供者：RadNet/DeepHealth、Solis、SimonMed、Mamotest 類型模式、Krsnaa 類型 PPP 模式和公共行動篩選計劃。
  • 光子計數檢測器、CEM 和堆疊：西門子、Canon/Ledren、Valex、GE、Hologic、檢測器供應商、造影劑供應商以及部分基礎技術的擁有者。

本報告關於競爭格局的一個關鍵結論是，沒有一家公司能夠主導所有層級。 Hologic 仍然是乳房健康領域中實力最強的老牌企業，而 GE 和 Siemens 正在可信企業級和 CEM/高階技術領域嶄露頭角，成為新的挑戰者。此外，軟體和人工智慧平台正日益影響影像解讀工作流程，而中國企業和中低階廠商則帶來了另一個維度的競爭張力：「單價與價值」。

本報告內容

核心模型：2024-2035

  • 測試次數
  • 已安裝單元數量
  • 年出貨量
  • 設備/龍門架銷售
  • 服務合約
  • 乳房X光攝影專用軟體和工作站
  • 人工智慧/工作流程軟體
  • 乳房X光攝影的主要市場
  • 乳腺介入治療途徑
  • 乳房超音波相關領域
  • 乳房磁振造影相關領域
  • 乳房攝影生態系中的商業機會

技術和工作流程的全面性

  • 2D FFDM
  • DBT/3D乳房X光攝影
  • 造影乳房X光攝影
  • 乳房X光攝影人工智慧檢測與第二閱片者工作流程
  • 密度與風險人工智慧
  • 企業級乳房工作流程與檢視器
  • 移動式乳房X光攝影及遠端乳房X光攝影
  • 乳房超音波和乳房MRI的鄰近檢查
  • 切片檢查和乳房介入工作流程
  • 光子計數乳房乳房X光攝影：定位為場景/觀察名單技術，而不是基本案例收入來源。

關於市場結構的觀點

  • 核心、通路與生態系的分母
  • 區域和國家特定的市場原型
  • 更換週期趨勢
  • 篩檢政策和使用情況的背景
  • 採購和競標慣例
  • 基於服務和部署的經濟學
  • CEM 和高階疊加策略
  • 彌合人工智慧貨幣化與服務提供者總附加價值之間的差距
  • 競爭對手控制平面分析

戰略框架

本報告運用了Marketstrat的Markintel®框架體系，其中包括M3市場動能矩陣、M-TEM、T-DIC、解決方案部署與成長矩陣、ARC指數、生態系統協作矩陣和升級包階梯。這些框架將模型輸出轉化為策略解讀，具體揭示了哪些細分市場值得投資、定價風險最高、人工智慧如何商業化，以及哪些技術具有商業性實用化或因證據或兌現要求而受阻。

目標區域

除了全球、北美、歐洲、亞太、拉丁美洲以及中東和非洲等區域市場外，本報告還分析了重點國家和特定叢集。區域模型區分了成熟的替代市場、准入拓展市場、篩檢專案市場、高階私人網路市場、公共/價值採購市場以及中國的雙通路結構。

這份報告的意義

本報告面向在乳房X光攝影和乳房攝影影像領域具有商業、產品、營運、投資或策略決策權的決策者，內容包括：

  • 乳房X光機OEM策略、產品、銷售及企業發展團隊
  • 乳房健康平台公司
  • 專注於人工智慧檢測、密度/風險評估、工作流程和編配。
  • 企業級醫學影像、PACS、閱片器和報告平台
  • 為乳房切片、立體定位成像和介入治療提供解決方案的公司。
  • 檢測器、CEM、造影劑及相關技術的供應商。
  • 醫療服務提供者網路、影像中心、行動篩檢營運商和遠距放射學平台
  • 投資者、銀行、私募股權和策略性收購公司
  • 銷售代理商和區域通路合作夥伴
  • 公共部門篩選、採購和准入基礎設施的相關人員

這份報告不僅是對市場規模的估算，更是一份策略路線圖，展示了乳房X光攝影的價值如何從硬體安裝轉向服務、工作流程、人工智慧、CEM、切片檢查、企業級閱片、基於供應商的經濟模式、行動存取和輔助成像藍圖。

報告詳情

  • 標題：全球乳房X光攝影展望：市場結構、預測、動態及人工智慧貨幣化架構（2024-2035年）
  • 類型：Marketstrat(R) 遠期報告
  • 報告編號：MINTH-M02137
  • 發售日期：2026年7月
  • 預測期：2024–2035年
  • 格式：PDF格式數位發行
  • 主要關注領域：乳房X光攝影系統、FFDM、DBT、CEM、乳房X光攝影AI/工作流程、服務和售後市場、移動乳房乳房X光攝影、乳房介入治療途徑、乳房超音波和乳房MRI相關領域。
  • 目標區域：全球、北美、歐洲、亞太地區、拉丁美洲、中東和非洲，以及主要國家和指定區域叢集。
  • 授權選項：個人（4,950 美元）、團隊版（5,450 美元）、企業版（8,950 美元）

目錄

第1章 -摘要整理

第2章 - 研究與調查方法

第3章 - 全球市場結構與策略框架

  • 戰略論點
  • 全球市場概覽
  • 成長促進因素
  • 成長抑制因素
  • 區域市場結構
  • M3市場動能矩陣 - 收入池
  • M-TEM技術成熟度評分
  • T-DIC技術擴散與影響曲線
  • 解決方案實施與成長矩陣
  • ARC-INDEX-商業化準備狀態
  • AI貨幣化地圖
  • 升級和套餐階梯
  • 生態系聯繫圖
  • 戰略框架概述

第4章 - 競爭格局

  • 競爭策略：乳房X光攝影的市場佔有率正從機架式攝影轉向控制平面攝影。
  • 極具競爭力的架構：八個叢集定義了市場。
  • 競爭控制平面記分卡
  • Marketstrut 競爭分析：乳房攝影領域競爭的五個特徵
  • 叢集1 - 系統 OEM/乳癌篩檢平台現有公司
  • 第二叢集－中國/低成本乳房X光檢查面臨的挑戰
  • 第三叢集－乳房人工智慧檢測和第二領先供應商
  • 叢集－用於人口密度、風險和團體健康的AI平台
  • 第五叢集- 企業影像、乳房工作流程與人工智慧編配平台
  • 第六叢集- 介入性乳房治療途徑與切片檢查生態系統
  • 叢集－醫療服務供應商網路、行動接取和遠端乳房X光檢查服務供應商
  • 8號叢集－包含檢測器、CEM和光子計數功能的堆疊
  • GTM成長成熟度矩陣 -參與企業
  • 競爭曝光熱圖
  • 不同類型球員的競爭態度
  • 一張有助於勝利的競爭地圖
  • 維持競爭優勢的耐久性排名
  • 企業集團的競爭策略
  • 從相關利益者的洞察到實際行動
  • 未來12-24個月值得關注的競爭趨勢
  • 最終競賽綜合分析

第5章 - 區域和各國市場分析

  • 乳房X光檢查是一個區域性政策市場，卻擁有全球平台經濟。
    • 區域世界預測概要
    • 當地市場的典型例子
  • 北美區域分析
  • 對美國進行國別分析
  • 加拿大國別分析
  • 歐洲區域分析
  • 德國國別分析
  • 法國國別分析
  • 英國國情分析
  • 義大利國別分析
  • 其他歐洲國家
  • 亞太地區區域分析
  • 中國國別分析
  • 日本國別分析
  • 印度國別分析
  • 韓國國別分析
  • 澳洲國別分析
  • 亞太地區的其他國家
  • 拉丁美洲區域分析
  • 對巴西進行國別分析
  • 墨西哥國別分析
  • 拉丁美洲其他地區
  • 中東和非洲區域分析
  • GCC
  • 南非共和國國別分析

第5章：總結討論－對區域戰略的影響

Product Code: MINTH-M02137

Report Overview

Mammography remains one of the most established screening infrastructure markets in medical imaging, but it is no longer best understood as a simple equipment replacement category. Dedicated mammography systems, DBT, CEM-capable gantries, service contracts, mammography-specific workflow software, AI, breast biopsy, mobile screening, and supplemental imaging pathways are increasingly connected through the same commercial decision chain.

This Marketstrat® Horizon report analyzes the global mammography market and the broader breast imaging ecosystem from 2024A to 2035F. It separates the Core Mammography Market from the Interventional Breast Pathway and the broader Breast Imaging Ecosystem Opportunity, allowing readers to distinguish the headline system-and-service denominator from adjacent procedure, ultrasound, MRI, access, and workflow value pools.

The central commercial question is no longer only “who sells the mammography gantry?” It is: who controls the breast imaging operating system around the gantry - replacement timing, service, AI, CEM, biopsy, enterprise workflow, provider economics, mobile access, and supplemental imaging routing? The report’s competitive thesis is that durable advantage is shifting from share of gantries toward share of control planes.

This Horizon report is Marketstrat’s in-depth global analysis of mammography and breast imaging market structure. It is built for medical imaging OEM executives, breast health strategy teams, AI and workflow vendors, enterprise imaging platforms, interventional breast technology companies, investors, private equity, distributors, provider networks, and public-sector imaging leaders.

The report covers screening and diagnostic mammography, FFDM, DBT, contrast-enhanced mammography, mammography-specific software and workstations, breast AI, density and risk tools, service contracts, mobile screening, image-guided breast intervention, and supplemental breast imaging pathways. It also evaluates how value migrates across mature replacement markets, access-expansion markets, screening-program markets, China’s two-channel procurement structure, and premium private-network breast imaging pathways.

The report is designed to answer practical commercial questions:

  • Where does mammography still grow when gantry hardware is mature?
  • Which value pools sit inside the Core Mammography Market, and which sit in adjacent breast imaging pathways?
  • How should vendors think about AI monetization when provider-gross value can be larger than vendor-booked software revenue?
  • Where is CEM most commercially relevant?
  • Which companies control the installed base, service, biopsy pathway, enterprise workflow, AI layer, provider volume, and China/value-tier channels?
  • How do regional strategies differ across the U.S., Europe, China, Japan, India, LATAM, and MEA?

Market Snapshot

The global mammography market is structurally mature but strategically active. The gantry pool remains the anchor, yet the most important growth and competitive movement is occurring around the gantry: AI/workflow software, CEM-enabled diagnostic pathways, service retention, interventional breast procedures, breast ultrasound, breast MRI, mobile access infrastructure, and risk-based screening.

The report’s market architecture separates three layers:

Core Mammography Market

Dedicated mammography systems, mammography-specific service, mammography-specific software/workstations, and mammography AI/workflow.

Interventional Breast Pathway

Biopsy systems, localization, image-guided intervention, and related downstream procedure economics.

Breast Imaging Ecosystem Opportunity

The Core Mammography Market plus the Interventional Breast Pathway and breast ultrasound/MRI adjacencies.

This matters because a flat or modestly growing gantry market can still control a larger and faster-moving ecosystem. The report’s framework analysis shows equipment and service as stable, installed-base-heavy pools, while AI/workflow, CEM, breast ultrasound, breast MRI, and biopsy/intervention drive a broader strategic opportunity.

Key Market Trends

1. Mammography is shifting from hardware replacement to ecosystem control

  • The strongest competitors are not simply those with the most installed gantries. They are the companies that can defend replacement accounts, attach service, integrate AI and workflow, enable CEM, support biopsy pathways, and keep the breast imaging study inside their operating environment.

2. DBT is becoming baseline in developed markets

  • DBT remains strategically important, but in many developed markets it is increasingly a replacement-cycle and premium-standard feature rather than a greenfield growth story. Future differentiation shifts toward workflow, patient experience, AI integration, CEM readiness, dose, acquisition speed, service, and fleet economics.

3. CEM is the most important near-term premium technology overlay

  • Contrast-enhanced mammography is not yet a broad screening standard, but it is strategically important for dense-breast workup, diagnostic problem-solving, selected MRI-substitution use cases, CEM-guided biopsy, and premium breast-center positioning. The report treats CEM as a practical near-term overlay rather than a distant frontier technology.

4. AI monetization must be separated from provider economics

  • The report distinguishes vendor-net AI/workflow revenue from provider-gross economics. Vendor revenue includes software, OEM-bundled AI, SaaS, enterprise subscriptions, and per-study fees. Provider-gross value includes patient-pay add-ons, workflow productivity, recall management, reimbursement, and downstream throughput. This separation avoids double counting and clarifies who captures value.

5. Breast ultrasound and breast MRI are not inside the core denominator, but they matter commercially

  • Supplemental imaging is central to the broader breast imaging pathway. Breast ultrasound and breast MRI are treated as adjacencies rather than core mammography revenue, but they materially shape diagnostic follow-up, dense-breast workflows, high-risk pathways, provider economics, and vendor ecosystem strategy.

6. Regional strategy is not one global adoption curve

  • The report frames mammography as a local policy and procurement market with global platform economics. Adoption is shaped by screening age bands, public-program design, insurance coverage, procurement systems, workforce constraints, provider-network structure, and local service capacity.

Competitive Landscape

Marketstrat structures the mammography market into eight competitive clusters because the market is increasingly shaped by control planes rather than a flat OEM ranking.

The report analyzes:

  • Systems OEMs / breast health platform incumbents: Hologic, GE HealthCare, Siemens Healthineers, Fujifilm, Canon Medical, Planmed, IMS/Giotto, and selected regional specialists.
  • China and value-tier challengers: United Imaging, Wandong, Mindray, Neusoft, Inkon, and regional distributors.
  • Breast AI detection and second-reader vendors: ScreenPoint, Lunit, DeepHealth/iCAD, Hologic Genius AI, Vara, Therapixel, CureMetrix, and related screening-AI assets.
  • Density, risk, and population-health AI platforms: Lunit/Volpara, Clairity, Densitas, b-rayZ, ScreenPoint/Biomediq, and DeepHealth.
  • Enterprise imaging, breast workflow, and AI orchestration platforms: Visage/Pro Medicus, Sectra, Fujifilm Synapse, Intelerad, GE, Siemens, Philips, Mach7, Agfa, Hyland, and related platforms.
  • Interventional breast pathway and biopsy ecosystem: Hologic, Mammotome, BD, Merit Medical, Leica/Danaher, GE, Siemens, and related procedure assets.
  • Provider networks, mobile access, and telemammography operators: RadNet/DeepHealth, Solis, SimonMed, Mamotest-like models, Krsnaa-like PPP models, and public mobile screening programs.
  • Detector, CEM, and photon-counting enabling stack: Siemens, Canon/Redlen, Varex, GE, Hologic, detector suppliers, contrast suppliers, and selected enabling-technology owners.

The report’s competitive conclusion is that no single company controls every layer. Hologic remains the strongest vertical breast-health incumbent, GE and Siemens are credible enterprise and CEM/premium-technology challengers, software and AI platforms increasingly influence reading workflow, and China/value-tier players create a different unit-versus-value competitive tension.

What's Inside

Core model: 2024A–2035F

  • Procedure volume
  • Installed base
  • Annual shipments
  • Equipment / gantry revenue
  • Service contracts
  • Mammography-specific software and workstations
  • AI / workflow software
  • Core Mammography Market
  • Interventional Breast Pathway
  • Breast Ultrasound Adjacency
  • Breast MRI Adjacency
  • Breast Imaging Ecosystem Opportunity

Technology and workflow coverage

  • 2D FFDM
  • DBT / 3D mammography
  • Contrast-enhanced mammography
  • Mammography AI detection and second-reader workflows
  • Density and risk AI
  • Enterprise breast workflow and viewers
  • Mobile mammography and telemammography
  • Breast ultrasound and breast MRI adjacencies
  • Biopsy and interventional breast workflow
  • Photon-counting mammography as a scenario/watchlist technology, not a base-case revenue pool

Market-structure views

  • Core vs pathway vs ecosystem denominator
  • Regional and country market archetypes
  • Replacement-cycle dynamics
  • Screening-policy and utilization context
  • Procurement and tender evidence
  • Service and installed-base economics
  • CEM and premium overlay strategy
  • AI monetization and provider-gross value bridge
  • Competitive control-plane analysis

Strategic frameworks

The report applies Marketstrat’s Markintel® framework stack, including M³ Market Momentum Matrix, M-TEM, T-DIC, Solution Adoption & Growth Matrix, ARC-Index, Ecosystem Collaboration Matrix, and Upgrade & Package Ladder. These frameworks translate model outputs into strategic interpretation: which segments deserve investment, where pricing risk is highest, where AI can be monetized, and which technologies are commercially ready versus evidence- or reimbursement-gated.

Geographic coverage

Global, North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, plus major countries and named clusters analyzed in the report. The regional model distinguishes mature replacement markets, access-expansion markets, screening-program markets, premium private-network markets, public/value procurement markets, and China’s two-channel structure.

Why This Report?

This report is designed for decision-makers with commercial, product, operational, investment, or strategic exposure to mammography and breast imaging, including:

  • Mammography OEM strategy, product, commercial, and corporate development teams
  • Breast health platform companies
  • AI detection, density/risk, workflow, and orchestration vendors
  • Enterprise imaging, PACS, viewer, and reporting platforms
  • Breast biopsy, localization, and interventional pathway companies
  • Detector, CEM, contrast, and enabling-technology suppliers
  • Provider networks, imaging centers, mobile screening operators, and teleradiology platforms
  • Investors, banks, private equity, and strategic acquirers
  • Distributors and regional channel partners
  • Public-sector screening, procurement, and access-infrastructure stakeholders

The report is not only a market-sizing document. It is a strategic map of how value is shifting around mammography: from hardware placement toward service, workflow, AI, CEM, biopsy, enterprise viewing, provider-volume economics, mobile access, and supplemental imaging routing.

Report Details

  • Title: Global Mammography Horizon: Market Structure, Forecasts, Competitive Dynamics, and AI Monetization Architecture, 2024A–2035F
  • Type: Marketstrat® Horizon Report
  • Report ID: MINTH-M02137
  • Publication: July 2026
  • Forecast Horizon: 2024A–2035F
  • Format: PDF digital delivery
  • Core Coverage: Mammography systems, FFDM, DBT, CEM, mammography AI/workflow, service and aftermarket, mobile mammography, interventional breast pathway, breast ultrasound, and breast MRI adjacencies
  • Geographic Coverage: Global, North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, plus major countries and named regional clusters
  • License Options: Individual ($4,950), Team ($5,450), Enterprise ($8,950)

Table of Contents

SECTION 1 – EXECUTIVE SUMMARY

  • 1.1 EXECUTIVE TAKEAWAYS
  • 1.2 THE 25-SECOND READ
  • 1.3 GLOBAL MARKET AT-A-GLANCE
  • 1.4 WHAT IS STRUCTURALLY CHANGING
  • 1.5 REGIONAL ARCHETYPES
  • 1.6 COMPETITIVE LANDSCAPE AT-A-GLANCE
  • 1.7 IMPLICATIONS-TO-ACTION
  • 1.8 SIGNALS TO WATCH OVER THE NEXT 12–24 MONTHS

SECTION 2 - RESEARCH & METHODOLOGY

  • 2.1 PURPOSE OF THE REPORT
  • 2.2 WHAT THIS REPORT IS - AND WHAT IT IS NOT
  • 2.3 RESEARCH FOUNDATION AND SOURCE STACK
  • 2.4 MARKET DEFINITION AND SEGMENTATION SCHEMA
  • 2.6 CORE MARKET SIZING AND FORECASTING METHODOLOGY
  • 2.7 AI / WORKFLOW METHODOLOGY
  • 2.8 REGIONAL FORECAST METHODOLOGY
  • 2.9 COMPETITIVE LANDSCAPE METHODOLOGY
  • 2.10 QA, RECONCILIATION, AND LIMITATIONS

SECTION 3 - WORLD MARKET STRUCTURE AND STRATEGIC FRAMEWORKS

  • 3.1 STRATEGIC THESIS
  • 3.2 GLOBAL MARKET SNAPSHOT
  • 3.3 GROWTH DRIVERS
  • 3.4 GROWTH CONSTRAINTS
  • 3.5 REGIONAL MARKET STRUCTURE
  • 3.6 M³ MARKET MOMENTUM MATRIX - REVENUE POOLS
  • 3.7 M-TEM - TECHNOLOGY MATURITY SCORING
  • 3.8 T-DIC - TECHNOLOGY DIFFUSION AND IMPACT CURVE
  • 3.9 SOLUTION ADOPTION & GROWTH MATRIX
  • 3.10 ARC-INDEX - COMMERCIALIZATION READINESS
  • 3.11 AI MONETIZATION MAP
  • 3.12 UPGRADE & PACKAGE LADDER
  • 3.13 ECOSYSTEM COLLABORATION MAP
  • 3.14 STRATEGIC FRAMEWORKS CLOSING SYNTHESIS

SECTION 4 - COMPETITIVE LANDSCAPE

  • 4.1 COMPETITIVE THESIS: MAMMOGRAPHY IS SHIFTING FROM SHARE OF GANTRIES TO SHARE OF CONTROL PLANES
  • 4.2 COMPETITIVE ARCHITECTURE: EIGHT CLUSTERS DEFINE THE MARKET
  • 4.3 COMPETITIVE CONTROL-PLANE SCORECARD
  • 4.4 MARKETSTRAT COMPETITIVE INSIGHT: FIVE WAYS MAMMOGRAPHY COMPETITION IS DIFFERENT
  • 4.5 CLUSTER 1 - SYSTEMS OEMS / BREAST HEALTH PLATFORM INCUMBENTS
    • Cluster Definition
    • Cluster Landscape: How Competition Works
    • What It Takes to Win in Cluster 1
    • Hologic
    • GE HealthCare
    • Siemens Healthineers
    • Fujifilm
    • Canon Medical
    • Planmed
    • IMS/Giotto
    • Cluster 1 Strategic Takeaways
    • 4.6 CLUSTER 2 - CHINA / VALUE-TIER MAMMOGRAPHY CHALLENGERS
    • Cluster Definition
    • Cluster Landscape: How Competition Works
    • What It Takes to Win in Cluster 2
    • United Imaging
    • Wandong
    • Mindray
    • Neusoft
    • Cluster 2 Strategic Takeaways
  • 4.7 CLUSTER 3 - BREAST AI DETECTION AND SECOND-READER VENDORS
    • Cluster Definition
    • Cluster Landscape: How Competition Works
    • ScreenPoint Medical
    • Lunit / Volpara
    • RadNet / DeepHealth / iCAD
    • Hologic Genius AI
    • Vara
    • Therapixel / MammoScreen
    • CureMetrix
    • Cluster 3 Strategic Takeaways
  • 4.8 CLUSTER 4 - DENSITY, RISK, AND POPULATION-HEALTH AI PLATFORMS
    • Cluster Definition
    • Cluster Landscape: How Competition Works
    • Lunit / Volpara
    • Clairity
    • Densitas
    • b-rayZ
    • DeepHealth
    • Cluster 4 Strategic Takeaways
  • 4.9 CLUSTER 5 - ENTERPRISE IMAGING, BREAST WORKFLOW, AND AI ORCHESTRATION PLATFORMS
    • Cluster Definition
    • Cluster Landscape: How Competition Works
    • Visage / Pro Medicus
    • Sectra
    • Fujifilm Synapse
    • Intelerad (GEHC)
    • GE HealthCare Enterprise Workflow
    • Siemens Healthineers Workflow
    • Aidoc aiOS and AI Orchestration Platforms
    • Cluster 5 Strategic Takeaways
  • 4.10 CROSS-CLUSTER SYNTHESIS - SOFTWARE CONTROL PLANES
  • 4.11 SOFTWARE CLUSTER CLOSING SYNTHESIS
  • 4.12 CLUSTER 6 - INTERVENTIONAL BREAST PATHWAY AND BIOPSY ECOSYSTEM
    • Cluster Definition
    • Cluster Landscape: How Competition Works
    • Hologic
    • Mammotome
    • BD
    • Merit Medical
    • GE HealthCare
    • Siemens Healthineers
    • Cluster 6 Strategic Takeaways
  • 4.13 CLUSTER 7 - PROVIDER NETWORKS, MOBILE ACCESS, AND TELEMAMMOGRAPHY OPERATORS
    • Cluster Definition
    • Cluster Landscape: How Competition Works
    • RadNet / DeepHealth
    • Solis Mammography
    • SimonMed Imaging
    • Mamotest-like Telemammography Platforms
    • Krsnaa-like PPP Diagnostic Networks
    • Public Mobile Screening Programs
    • Cluster 7 Strategic Takeaways
  • 4.14 CLUSTER 8 - DETECTOR, CEM, AND PHOTON-COUNTING ENABLING STACK
    • Cluster Definition
    • Cluster Landscape: How Competition Works
    • GE HealthCare
    • Hologic
    • Siemens Healthineers
    • Canon / Redlen
    • Varex / Direct Conversion
    • Calidar
    • Bayer, Bracco, and Guerbet
    • United Imaging
    • Cluster 8 Strategic Takeaways
  • 4.15 CROSS-CLUSTER SYNTHESIS - DOWNSTREAM AND ENABLING CONTROL PLANES
  • 4.16 DOWNSTREAM AND ENABLING CONTROL PLANES - CLOSING SYNTHESIS
  • 4.17 COMPETITIVE CAPSTONE - FROM VENDOR RANKING TO STRATEGIC CONTROL
    • Key Takeaways
  • 4.18 GTM GROWTH–MATURITY MATRIX - MAMMOGRAPHY ECOSYSTEM PLAYERS
    • Framework Definition
    • Competitive Context
    • Strategic Takeaways - GTM Growth–Maturity Matrix
  • 4.19 COMPETITIVE EXPOSURE HEATMAP
    • Purpose of the Exposure Heatmap
    • Exposure Heatmap Interpretation
  • 4.20 COMPETITIVE STANCE BY PLAYER TYPE
  • 4.21 WHERE-TO-WIN COMPETITIVE MAP
  • 4.22 COMPETITIVE MOAT DURABILITY LADDER
    • Moat Interpretation
  • 4.23 COMPETITIVE PLAYBOOK BY COMPANY CLUSTER
  • 4.24 INSIGHTS-TO-ACTION BY STAKEHOLDER
  • 4.25 COMPETITIVE SIGNALS TO WATCH OVER THE NEXT 12–24 MONTHS
  • 4.26 FINAL COMPETITIVE SYNTHESIS

SECTION 5 - REGIONAL AND COUNTRY MARKET ANALYSIS

  • 5.1 GLOBAL REGIONAL LENS: MAMMOGRAPHY IS A LOCAL POLICY MARKET WITH GLOBAL PLATFORM ECONOMICS
    • Global Forecast Summary by Region
    • Regional Market Archetypes
  • 5.2 NORTH AMERICA REGIONAL ANALYSIS
    • Key Takeaways
    • North America Market Landscape
    • North America Market Snapshot
    • Demand, Screening, and Socioeconomic Context
    • North America Bottom Line
  • 5.3 UNITED STATES COUNTRY ANALYSIS
    • U.S. Market Landscape
    • U.S. Market Forecast
    • U.S. Installed Base, Utilization, and Replacement Economics
    • U.S. Screening Policy, Regulation, and Reimbursement Context
    • U.S. Technology Adoption: DBT, CEM, PCM, AI, and Mobile
    • U.S. Competitive and Channel Dynamics
    • U.S. Growth Drivers and Constraints
    • U.S. Bottom Line
  • 5.4 CANADA COUNTRY ANALYSIS
    • Canada Market Landscape
    • Canada Market Forecast
    • Canada Health-System, Screening, and Procurement Context
    • Canada Installed Base, Utilization, and Replacement Economics
    • Canada Technology Adoption: DBT, CEM, PCM, AI, and Mobile
    • Canada Competitive and Channel Dynamics
    • Canada Growth Drivers and Constraints
    • Canada Bottom Line
  • 5.5 EUROPE REGIONAL ANALYSIS
    • Key Takeaways
    • Europe Market Landscape
    • Disease, Demographic, and Screening Context
    • Health-System, Reimbursement, and Procurement Context
    • Installed Base, Utilization, and Replacement Economics
    • Technology Adoption: DBT, CEM, PCM, AI, and Mobile
    • Competitive and Channel Dynamics
    • Europe Growth Drivers and Constraints
    • Europe Bottom Line
  • 5.6 GERMANY COUNTRY ANALYSIS
    • Key Takeaways
    • Germany Market Landscape
    • Germany Market Forecast
    • Germany Disease and Demographic Demand Context
    • Germany Health-System, Reimbursement, and Procurement Context
    • Germany Installed Base, Utilization, and Replacement Economics
    • Germany Technology Adoption: DBT, CEM, PCM, AI, and Mobile
    • Germany Competitive and Channel Dynamics
    • Germany Growth Drivers and Constraints
    • Germany Bottom Line
  • 5.7 FRANCE COUNTRY ANALYSIS
    • Key Takeaways
    • France Market Landscape
    • France Market Forecast
    • France Disease and Demographic Demand Context
    • France Health-System, Reimbursement, and Procurement Context
    • France Installed Base, Utilization, and Replacement Economics
    • France Technology Adoption: DBT, CEM, PCM, AI, and Mobile
    • France Competitive and Channel Dynamics
    • France Growth Drivers and Constraints
    • France Bottom Line
  • 5.8 UNITED KINGDOM COUNTRY ANALYSIS
    • Key Takeaways
    • United Kingdom Market Landscape & Forecast
    • United Kingdom Disease and Demographic Demand Context
    • United Kingdom Health-System, Reimbursement, and Procurement Context
    • United Kingdom Installed Base, Utilization, and Replacement Economics
    • United Kingdom Technology Adoption: DBT, CEM, PCM, AI, and Mobile
    • United Kingdom Competitive and Channel Dynamics
    • United Kingdom Growth Drivers and Constraints
    • United Kingdom Bottom Line
  • 5.9 ITALY COUNTRY ANALYSIS
    • Key Takeaways
    • Italy Market Landscape & Forecast
    • Italy Disease and Demographic Demand Context
    • Italy Health-System, Reimbursement, and Procurement Context
    • Italy Installed Base, Utilization, and Replacement Economics
    • Italy Technology Adoption: DBT, CEM, PCM, AI, and Mobile
    • Italy Competitive and Channel Dynamics
    • Italy Growth Drivers and Constraints
    • Italy Bottom Line
  • 5.10 REST OF EUROPE NAMED CLUSTERS
    • Cluster Overview
    • Market Forecast by Cluster - ROE
    • Spain / Iberia
    • Nordics
    • Benelux
    • Central and Eastern Europe
    • EUROPE CLOSING SYNTHESIS
  • 5.11 ASIA-PACIFIC REGIONAL ANALYSIS
    • Key Takeaways
    • APAC Market Landscape
    • APAC Market Forecast by Revenue Pool / Market View
    • APAC Market Forecast by Country/Regional Cluster
    • APAC Demand, Screening, and Socioeconomic Context
    • APAC Health-System, Reimbursement, and Procurement Context
    • APAC Installed Base, Utilization, and Replacement Economics
    • APAC Technology Adoption: DBT, CEM, PCM, AI, and Mobile
    • APAC Competitive and Channel Dynamics
    • APAC Growth Drivers and Constraints
    • APAC Bottom Line
  • 5.12 CHINA COUNTRY ANALYSIS
    • Key Takeaways
    • China Market Landscape & Forecast
    • China Disease and Demographic Demand Context
    • China Health-System, Reimbursement, and Procurement Context
    • China Two-Channel Market Structure
    • China Installed Base, Utilization, and Replacement Economics
    • China Technology Adoption: DBT, CEM, PCM, AI, and Mobile
    • China Competitive and Channel Dynamics
    • China Growth Drivers and Constraints
    • China Bottom Line
  • 5.13 JAPAN COUNTRY ANALYSIS
    • Key Takeaways
    • Japan Market Landscape & Forecast
    • Japan Disease and Demographic Demand Context
    • Japan Health-System, Reimbursement, and Procurement Context
    • Japan Installed Base, Utilization, and Replacement Economics
    • Japan Technology Adoption: DBT, CEM, PCM, AI, and Mobile
    • Japan Competitive and Channel Dynamics
    • Japan Growth Drivers and Constraints
    • Japan Bottom Line
  • 5.14 INDIA COUNTRY ANALYSIS
    • Key Takeaways
    • India Market Landscape & Forecast
    • India Disease and Demographic Demand Context
    • India Health-System, Reimbursement, and Procurement Context
    • India Installed Base, Utilization, and Replacement Economics
    • India Technology Adoption: FFDM, DBT, CEM, AI, Breast US, and Mobile
    • India Competitive and Channel Dynamics
    • India Growth Drivers and Constraints
    • India Bottom Line
  • 5.15 SOUTH KOREA COUNTRY ANALYSIS
    • Key Takeaways
    • South Korea Market Landscape & Forecast
    • South Korea Disease and Demographic Demand Context
    • South Korea Health-System, Reimbursement, and Procurement Context
    • South Korea Installed Base, Utilization, and Replacement Economics
    • South Korea Technology Adoption: DBT, CEM, AI, Breast US, and Mobile
    • South Korea Competitive and Channel Dynamics
    • South Korea Growth Drivers and Constraints
    • South Korea Bottom Line
  • 5.16 AUSTRALIA COUNTRY ANALYSIS
    • Key Takeaways
    • Australia Market Landscape
    • Australia Disease and Demographic Demand Context
    • Australia Health-System, Reimbursement, and Procurement Context
    • Australia Installed Base, Utilization, and Replacement Economics
    • Australia Technology Adoption: DBT, CEM, AI, Breast US/MRI, and Mobile
    • Australia Competitive and Channel Dynamics
    • Australia Growth Drivers and Constraints
    • Australia Bottom Line
  • 5.17 REST OF APAC (ROAPAC) NAMED CLUSTERS
    • Cluster Overview
    • Rest of APAC Forecast by Regional Cluster
    • Advanced ROAPAC
    • ASEAN
    • South Asia ex-India
    • Other Emerging APAC
    • ROAPAC Closing Synthesis
  • 5.18 LATIN AMERICA REGIONAL ANALYSIS
    • Key Takeaways
    • LATAM Market Landscape & Forecast
    • LATAM Demand, Screening, and Socioeconomic Context
    • LATAM Health-System, Reimbursement, and Procurement Context
    • LATAM Installed Base, Utilization, and Replacement Economics
    • LATAM Technology Adoption: FFDM, DBT, CEM, AI, Breast US/MRI, and Mobile
    • LATAM Competitive and Channel Dynamics
    • LATAM Growth Drivers and Constraints
    • LATAM Bottom Line
  • 5.19 BRAZIL COUNTRY ANALYSIS
    • Key Takeaways
    • Brazil Market Landscape & Forecast
    • Brazil Demand and Screening Context
    • Brazil Health-System, Reimbursement, and Procurement Context
    • Brazil Technology Adoption: FFDM, DBT, CEM, AI, Breast US/MRI, and Mobile
    • Brazil Competitive and Channel Dynamics
    • Brazil Growth Drivers and Constraints
    • Brazil Bottom Line
  • 5.20 MEXICO COUNTRY ANALYSIS
    • Key Takeaways
    • Mexico Market Landscape & Forecast
    • Mexico Demand and Screening Context
    • Mexico Health-System, Reimbursement, and Procurement Context
    • Mexico Installed Base, Utilization, and Replacement Economics
    • Mexico Technology Adoption: FFDM, DBT, CEM, AI, Breast US/MRI, and Mobile
    • Mexico Competitive and Channel Dynamics
    • Mexico Growth Drivers and Constraints
    • Mexico Bottom Line
  • 5.21 REST OF LATAM NAMED CLUSTER
    • Cluster Overview
    • Rest of LATAM Forecast by Revenue Pool/Market View
    • Rest of LATAM Market Structure and Strategic Readiness
    • Rest of LATAM Bottom Line
  • 5.22 MIDDLE EAST & AFRICA REGIONAL ANALYSIS
    • Key Takeaways
    • MEA Market Landscape
    • MEA Forecast by Revenue Pool / Market View
    • MEA Demand, Screening, and Socioeconomic Context
    • MEA Health-System, Reimbursement, and Procurement Context
    • MEA Installed Base, Utilization, and Replacement Economics
    • MEA Technology Adoption: FFDM, DBT, CEM, AI, Breast US/MRI, and Mobile
    • MEA Competitive and Channel Dynamics
    • MEA Growth Drivers and Constraints
    • MEA Bottom Line
  • 5.23 GCC NAMED CLUSTER
    • Cluster Overview
    • GCC Forecast by Revenue Pool / Market View
    • GCC Market Structure and Strategic Readiness
    • GCC Bottom Line
  • 5.24 SOUTH AFRICA COUNTRY ANALYSIS
    • Key Takeaways
    • South Africa Market Landscape & Forecast
    • South Africa Demand and Screening Context
    • South Africa Health-System, Reimbursement, and Procurement Context
    • South Africa Installed Base, Utilization, and Replacement Economics
    • South Africa Technology Adoption: Mammography, Ultrasound, Biopsy, AI, and Mobile
    • South Africa Competitive and Channel Dynamics
    • South Africa Growth Drivers and Constraints
    • South Africa Bottom Line
  • 5.25 REST OF MEA ACCESS-INFRASTRUCTURE CLUSTER
    • Cluster Overview
    • Rest of MEA Forecast
    • Rest of MEA Market Structure and Strategic Readiness Rest of MEA Bottom Line

SECTION 5 CLOSING SYNTHESIS - REGIONAL STRATEGY IMPLICATIONS

List of Figures

  • FIGURE 1: EXECUTIVE “SO-WHAT” DASHBOARD
  • FIGURE 2: GLOBAL MAMMOGRAPHY MARKET ECOSYSTEM ARCHITECTURE
  • FIGURE 3: REGIONAL ARCHETYPE SCALE AND GROWTH MAP
  • FIGURE 4: FRONTIER TECHNOLOGY WATCHLIST
  • FIGURE 5: AI VENDOR-NET TO PROVIDER-GROSS VALUE BRIDGE
  • FIGURE 6: CORE MAMMOGRAPHY MARKET MIX SHIFT
  • FIGURE 7: BREAST IMAGING ECOSYSTEM ENRICHMENT RATIO
  • FIGURE 8: MAMMOGRAPHY GROWTH CONTRIBUTION AND VALUE MIGRATION
  • FIGURE 9: CEM, MRI, AND ULTRASOUND DIAGNOSTIC PATHWAY COMPARISON
  • FIGURE 10: M³ MARKET MOMENTUM MATRIX - MAMMOGRAPHY REVENUE POOLS
  • FIGURE 11: M-TEM TECHNOLOGY MATURITY HEATMAP
  • FIGURE 12: COMPETITIVE CONTROL-PLANE SCORECARD
  • FIGURE 13: T-DIC TECHNOLOGY DIFFUSION AND IMPACT CURVE
  • FIGURE 14: ARC-INDEX COMMERCIALIZATION READINESS
  • FIGURE 15: MAMMOGRAPHY UPGRADE & PACKAGE LADDER
  • FIGURE 16: FROM SHARE OF GANTRIES TO SHARE OF CONTROL PLANES
  • FIGURE 17: THE MAMMOGRAPHY MARKET IS EIGHT CONTROL PLANES, NOT ONE
  • FIGURE 18: STRATEGIC CONTROL PLANE POSITION
  • FIGURE 19: INCUMBENT EXPOSURE ACROSS THE EIGHT CONTROL PLANES
  • FIGURE 20: U.S. REPLACEMENT CYCLE AND ENVISION EXPOSURE MAP
  • FIGURE 21: BREAST AI PLATFORM CONSOLIDATION MAP
  • FIGURE 22: BREAST AI EVIDENCE AND DEPLOYMENT READINESS MAP
  • FIGURE 23: INTERVENTIONAL BREAST PATHWAY CONTROL-PLANE MAP
  • FIGURE 24: MOBILE AND TELEMAMMOGRAPHY ACCESS MODEL MAP
  • FIGURE 25: CEM-GUIDED BIOPSY PATHWAY MAP
  • FIGURE 26: GTM GROWTH–MATURITY MATRIX - MAMMOGRAPHY ECOSYSTEM PLAYERS
  • FIGURE 27: COUNTRY ARCHETYPE TILES
  • FIGURE 28: COMPETITIVE EXPOSURE HEATMAP
  • FIGURE 29: REGIONAL WHERE-TO-WIN HEATMAP
  • FIGURE 30: U.S. HOLOGIC INSTALLED BASE AND REPLACEMENT ECONOMICS
  • FIGURE 31: EUROPE SCREENING AI READINESS MAP
  • FIGURE 32: CHINA TWO-CHANNEL PROCUREMENT MAP
  • FIGURE 33: CHINA PUBLIC/VALUE PRESSURE AND PREMIUM DEFENSE MAP

List of Tables

  • TABLE 1: GLOBAL MAMMOGRAPHY EXECUTIVE DASHBOARD, 2024A–2035F
  • TABLE 2: GLOBAL MAMMOGRAPHY MARKET AT-A-GLANCE, 2024A–2035F
  • TABLE 3: VALUE MIGRATION IN MAMMOGRAPHY - FROM SYSTEM SALE TO BREAST IMAGING OPERATING SYSTEM
  • TABLE 4: GLOBAL MAMMOGRAPHY REGIONAL ARCHETYPES
  • TABLE 5: COMPETITIVE LANDSCAPE AT-A-GLANCE - STRATEGIC CONTROL PLANES
  • TABLE 6: EXECUTIVE IMPLICATIONS-TO-ACTION BY STAKEHOLDER
  • TABLE 7: MAMMOGRAPHY MARKET SIGNALS TO WATCH
  • TABLE 8: STANDARDIZED SOURCE STACK AND USAGE RULES
  • TABLE 9: MAMMOGRAPHY MARKET DEFINITION AND DENOMINATOR SCHEMA
  • TABLE 10: REVENUE STREAM DEFINITIONS USED IN THE FORECAST
  • TABLE 11: CORE FORECAST CONSTRUCTION LOGIC
  • TABLE 12: AI / WORKFLOW MONETIZATION ARCHITECTURE
  • TABLE 13: AI VALUE BRIDGE - VENDOR-NET REVENUE VS PROVIDER-GROSS ECONOMICS (USD MILLIONS)
  • TABLE 14: REGIONAL FORECAST ARCHETYPE METHODOLOGY
  • TABLE 15: COMPETITIVE ASSESSMENT METHODOLOGY
  • TABLE 16: FORECAST QA AND INTERPRETATION GUARDRAILS
  • TABLE 17: GLOBAL MAMMOGRAPHY REVENUE FORECAST BY STREAM, 2024A–2035F (USD MILLIONS)
  • TABLE 18: GLOBAL BREAST IMAGING ECOSYSTEM OPPORTUNITY, 2024A–2035F (USD MILLIONS)
  • TABLE 19: GLOBAL DEMAND, INSTALLED BASE, AND SHIPMENT METRICS, 2024A–2035F
  • TABLE 20: GLOBAL MAMMOGRAPHY GROWTH DRIVERS
  • TABLE 21: GLOBAL MAMMOGRAPHY GROWTH CONSTRAINTS
  • TABLE 22: REGIONAL FORECAST SUMMARY - CORE MAMMOGRAPHY MARKET AND BREAST IMAGING ECOSYSTEM OPPORTUNITY (USD MILLIONS)
  • TABLE 23: M³ MARKET MOMENTUM MATRIX - MAMMOGRAPHY REVENUE POOLS
  • TABLE 24: SEGMENT MOMENTUM SNAPSHOT - REVENUE POOLS
  • TABLE 25: M-TEM SCORECARD - MAMMOGRAPHY TECHNOLOGY STACK
  • TABLE 26: T-DIC - MAMMOGRAPHY TECHNOLOGY DIFFUSION AND IMPACT CURVE
  • TABLE 27: SOLUTION ADOPTION & GROWTH MATRIX - MAMMOGRAPHY AI / WORKFLOW / TECHNOLOGY USE CASES
  • TABLE 28: ARC-INDEX - MAMMOGRAPHY TECHNOLOGIES AND AI / WORKFLOW USE CASES (SCORING SCALE: 0–100)
  • TABLE 29: MAMMOGRAPHY AI USE-CASE MONETIZATION MAP
  • TABLE 30: MAMMOGRAPHY UPGRADE & PACKAGE LADDER - COMMERCIAL PACKAGING ARCHITECTURE
  • TABLE 31: ECOSYSTEM COLLABORATION MAP - MAMMOGRAPHY CONTROL PLANES
  • TABLE 32: MAMMOGRAPHY COMPETITIVE LANDSCAPE MAP - CLUSTER ARCHITECTURE
  • TABLE 33: MAMMOGRAPHY COMPETITIVE CONTROL-PLANE SCORECARD
  • TABLE 34: FIVE COMPETITIVE MODELS IN MAMMOGRAPHY
  • TABLE 35: SYSTEMS OEM WINNING FACTORS
  • TABLE 36: CHINA / VALUE-TIER CHALLENGER WINNING FACTORS
  • TABLE 37: BREAST AI DETECTION AND SECOND-READER CLUSTER - COMPETITIVE FACTORS
  • TABLE 38: BREAST AI DETECTION AND SECOND-READER VENDORS - COMPETITIVE DATASET
  • TABLE 39: BREAST AI DETECTION CLUSTER - WHAT IT TAKES TO WIN
  • TABLE 40: DENSITY, RISK, AND POPULATION-HEALTH AI CLUSTER - COMPETITIVE FACTORS
  • TABLE 41: DENSITY, RISK, AND POPULATION-HEALTH AI VENDORS - COMPETITIVE DATASET
  • TABLE 42: DENSITY / RISK AI - HOW VALUE FLOWS INTO THE BREAST IMAGING ECOSYSTEM
  • TABLE 43: ENTERPRISE IMAGING AND BREAST WORKFLOW CLUSTER - COMPETITIVE FACTORS
  • TABLE 44: ENTERPRISE IMAGING AND BREAST WORKFLOW PLATFORMS - COMPETITIVE DATASET
  • TABLE 45: MAMMOGRAPHY WORKFLOW CONTROL - OEM WORKSTATION VS ENTERPRISE VIEWER VS AI ORCHESTRATION
  • TABLE 46: SOFTWARE CONTROL-PLANE MAP - WHO CONTROLS WHAT?
  • TABLE 47: SOFTWARE CLUSTER GROWTH–MATURITY POSITIONING
  • TABLE 48: SOFTWARE CLUSTER STRATEGIC TAKEAWAYS - DETECTION, RISK, AND WORKFLOW
  • TABLE 49: INTERVENTIONAL BREAST PATHWAY - COMPETITIVE FACTORS
  • TABLE 50: INTERVENTIONAL BREAST PATHWAY - COMPETITIVE DATASET
  • TABLE 51: INTERVENTIONAL BREAST PATHWAY - WHAT IT TAKES TO WIN
  • TABLE 52: PROVIDER NETWORKS, MOBILE ACCESS, AND TELEMAMMOGRAPHY - COMPETITIVE FACTORS
  • TABLE 53: PROVIDER NETWORKS, MOBILE ACCESS, AND TELEMAMMOGRAPHY - COMPETITIVE DATASET
  • TABLE 54: MOBILE MAMMOGRAPHY AND TELEMAMMOGRAPHY - MARKET STRUCTURE VIEW
  • TABLE 55: DETECTOR, CEM, AND PHOTON-COUNTING ENABLING STACK - COMPETITIVE FACTORS
  • TABLE 56: DETECTOR, CEM, AND PHOTON-COUNTING STACK - COMPETITIVE DATASET
  • TABLE 57: CEM, PCM, AND DETECTOR STACK - BASE CASE VS WATCHLIST TREATMENT
  • TABLE 58: DOWNSTREAM AND ENABLING CONTROL-PLANE MAP
  • TABLE 59: DOWNSTREAM AND ENABLING STRATEGIC TAKEAWAYS - WHERE COMPETITIVE ADVANTAGE MOVES DOWNSTREAM.
  • TABLE 60: GTM GROWTH–MATURITY QUADRANT DEFINITIONS
  • TABLE 61: GTM GROWTH–MATURITY MATRIX - SELECTED MAMMOGRAPHY ECOSYSTEM PLAYERS
  • TABLE 62: GROWTH & MATURITY HIGHLIGHTS - SELECTED HIGH-IMPACT PLAYERS
  • TABLE 63: COMPETITIVE EXPOSURE HEATMAP - SELECTED MAMMOGRAPHY ECOSYSTEM PLAYERS
  • TABLE 64: HOW TO INTERPRET THE EXPOSURE HEATMAP
  • TABLE 65: COMPETITIVE STANCE BY PLAYER TYPE - STRATEGIC POSTURE AND REQUIRED MOVES
  • TABLE 66: WHERE EACH PLAYER TYPE IS BEST POSITIONED TO WIN
  • TABLE 67: MAMMOGRAPHY COMPETITIVE MOAT DURABILITY LADDER
  • TABLE 68: COMPETITIVE PLAYBOOK - HOW EACH CLUSTER SHOULD ACT
  • TABLE 69: COMPETITIVE INSIGHTS-TO-ACTION
  • TABLE 70: COMPETITIVE SIGNALS TO WATCH
  • TABLE 71: GLOBAL REGIONAL FORECAST SUMMARY - CORE MAMMOGRAPHY MARKET AND BREAST IMAGING ECOSYSTEM OPPORTUNITY, 2024A–2035F (USD MILLIONS)
  • TABLE 72: REGIONAL MARKET ARCHETYPES - WHAT DRIVES VALUE BY GEOGRAPHY
  • TABLE 73: NORTH AMERICA MAMMOGRAPHY MARKET FORECAST BY REVENUE POOL, 2024A–2035F (USD MILLIONS)
  • TABLE 74: NORTH AMERICA DEMAND AND SCREENING CONTEXT
  • TABLE 75: UNITED STATES MAMMOGRAPHY MARKET FORECAST BY REVENUE POOL, 2024A–2035F (USD MILLIONS)
  • TABLE 76: UNITED STATES DEMAND AND SCREENING CONTEXT
  • TABLE 77: UNITED STATES INSTALLED BASE AND TECHNOLOGY ECONOMICS
  • TABLE 78: UNITED STATES REGULATORY, REIMBURSEMENT, AND PROCUREMENT STRUCTURE
  • TABLE 79: UNITED STATES TECHNOLOGY MATURITY AND COMMERCIAL READINESS
  • TABLE 80: UNITED STATES COMPETITIVE AND CHANNEL STRUCTURE
  • TABLE 81: UNITED STATES GROWTH DRIVERS AND CONSTRAINTS
  • TABLE 82: CANADA DEMAND AND SCREENING CONTEXT
  • TABLE 83: CANADA MAMMOGRAPHY MARKET FORECAST BY REVENUE POOL, 2024A–2035F (USD MILLIONS)
  • TABLE 84: CANADA HEALTH-SYSTEM, REIMBURSEMENT, AND PROCUREMENT STRUCTURE
  • TABLE 85: CANADA INSTALLED BASE AND TECHNOLOGY ECONOMICS
  • TABLE 86: CANADA TECHNOLOGY MATURITY AND COMMERCIAL READINESS
  • TABLE 87: CANADA COMPETITIVE AND CHANNEL STRUCTURE
  • TABLE 88: CANADA GROWTH DRIVERS AND CONSTRAINTS
  • TABLE 89: EUROPE MAMMOGRAPHY MARKET FORECAST BY REVENUE POOL, 2024A–2035F (USD MILLIONS)
  • TABLE 90: EUROPE DEMAND, DEMOGRAPHIC, AND SCREENING CONTEXT
  • TABLE 91: EUROPE HEALTH-SYSTEM, REIMBURSEMENT, AND PROCUREMENT STRUCTURE
  • TABLE 92: EUROPE INSTALLED BASE AND UTILIZATION ECONOMICS
  • TABLE 93: EUROPE TECHNOLOGY MATURITY AND COMMERCIAL READINESS
  • TABLE 94: EUROPE COMPETITIVE AND CHANNEL STRUCTURE
  • TABLE 95: EUROPE GROWTH DRIVERS AND CONSTRAINTS
  • TABLE 96: GERMANY MAMMOGRAPHY MARKET FORECAST BY REVENUE POOL, 2024A–2035F (USD MILLIONS)
  • TABLE 97: GERMANY DEMAND AND SCREENING CONTEXT
  • TABLE 98: GERMANY HEALTH-SYSTEM, REIMBURSEMENT, AND PROCUREMENT STRUCTURE
  • TABLE 99: GERMANY INSTALLED BASE AND TECHNOLOGY ECONOMICS
  • TABLE 100: GERMANY TECHNOLOGY MATURITY AND COMMERCIAL READINESS
  • TABLE 101: GERMANY COMPETITIVE AND CHANNEL STRUCTURE
  • TABLE 102: GERMANY GROWTH DRIVERS AND CONSTRAINTS
  • TABLE 103: FRANCE MAMMOGRAPHY MARKET FORECAST BY REVENUE POOL, 2024A–2035F (USD MILLIONS)
  • TABLE 104: FRANCE DEMAND AND SCREENING CONTEXT
  • TABLE 105: FRANCE HEALTH-SYSTEM, REIMBURSEMENT, AND PROCUREMENT STRUCTURE
  • TABLE 106: FRANCE INSTALLED BASE AND TECHNOLOGY ECONOMICS
  • TABLE 107: FRANCE TECHNOLOGY MATURITY AND COMMERCIAL READINESS
  • TABLE 108: FRANCE COMPETITIVE AND CHANNEL STRUCTURE
  • TABLE 109: FRANCE GROWTH DRIVERS AND CONSTRAINTS
  • TABLE 110: UNITED KINGDOM MAMMOGRAPHY MARKET FORECAST BY REVENUE POOL, 2024A–2035F (USD MILLIONS)
  • TABLE 111: UNITED KINGDOM DEMAND AND SCREENING CONTEXT
  • TABLE 112: UNITED KINGDOM HEALTH-SYSTEM, REIMBURSEMENT, AND PROCUREMENT STRUCTURE
  • TABLE 113: UNITED KINGDOM INSTALLED BASE AND TECHNOLOGY ECONOMICS
  • TABLE 114: UNITED KINGDOM TECHNOLOGY MATURITY AND COMMERCIAL READINESS
  • TABLE 115: UNITED KINGDOM COMPETITIVE AND CHANNEL STRUCTURE
  • TABLE 116: UNITED KINGDOM GROWTH DRIVERS AND CONSTRAINTS
  • TABLE 117: ITALY MAMMOGRAPHY MARKET FORECAST BY REVENUE POOL, 2024A–2035F (USD MILLIONS)
  • TABLE 118: ITALY DEMAND AND SCREENING CONTEXT
  • TABLE 119: ITALY HEALTH-SYSTEM, REIMBURSEMENT, AND PROCUREMENT STRUCTURE
  • TABLE 120: ITALY INSTALLED BASE AND TECHNOLOGY ECONOMICS
  • TABLE 121: ITALY TECHNOLOGY MATURITY AND COMMERCIAL READINESS
  • TABLE 122: ITALY COMPETITIVE AND CHANNEL STRUCTURE
  • TABLE 123: ITALY GROWTH DRIVERS AND CONSTRAINTS
  • TABLE 124: EUROPE NAMED-CLUSTER FORECAST SUMMARY, 2024A–2035F (USD MILLIONS)
  • TABLE 125: SPAIN / IBERIA MARKET STRUCTURE AND STRATEGIC READINESS
  • TABLE 126: NORDICS MARKET STRUCTURE AND STRATEGIC READINESS
  • TABLE 127: BENELUX MARKET STRUCTURE AND STRATEGIC READINESS
  • TABLE 128: CENTRAL AND EASTERN EUROPE MARKET STRUCTURE AND STRATEGIC READINESS
  • TABLE 129: EUROPE NAMED-CLUSTER COMMERCIAL PLAYBOOK
  • TABLE 130: ASIA-PACIFIC MAMMOGRAPHY MARKET FORECAST BY REVENUE POOL, 2024A–2035F (USD MILLIONS)
  • TABLE 131: APAC COUNTRY AND NAMED-CLUSTER FORECAST SUMMARY, 2024A–2035F (USD MILLIONS)
  • TABLE 132: APAC DEMAND, SCREENING, AND POLICY CONTEXT
  • TABLE 133: APAC HEALTH-SYSTEM, REIMBURSEMENT, AND PROCUREMENT STRUCTURE
  • TABLE 134: APAC INSTALLED BASE AND UTILIZATION ECONOMICS
  • TABLE 135: APAC TECHNOLOGY MATURITY AND COMMERCIAL READINESS
  • TABLE 136: APAC COMPETITIVE AND CHANNEL STRUCTURE
  • TABLE 137: APAC GROWTH DRIVERS AND CONSTRAINTS
  • TABLE 138: CHINA MAMMOGRAPHY MARKET FORECAST BY REVENUE POOL, 2024A–2035F (USD MILLIONS)
  • TABLE 139: CHINA DEMAND AND SCREENING CONTEXT
  • TABLE 140: CHINA HEALTH-SYSTEM, REIMBURSEMENT, AND PROCUREMENT STRUCTURE
  • TABLE 141: CHINA TWO-CHANNEL MAMMOGRAPHY MARKET STRUCTURE
  • TABLE 142: CHINA INSTALLED BASE AND TECHNOLOGY ECONOMICS
  • TABLE 143: CHINA TECHNOLOGY MATURITY AND COMMERCIAL READINESS
  • TABLE 144: CHINA COMPETITIVE AND CHANNEL STRUCTURE
  • TABLE 145: CHINA GROWTH DRIVERS AND CONSTRAINTS
  • TABLE 146: JAPAN MAMMOGRAPHY MARKET FORECAST BY REVENUE POOL, 2024A–2035F (USD MILLIONS)
  • TABLE 147: JAPAN DEMAND AND SCREENING CONTEXT
  • TABLE 148: JAPAN HEALTH-SYSTEM, REIMBURSEMENT, AND PROCUREMENT STRUCTURE
  • TABLE 149: JAPAN INSTALLED BASE AND TECHNOLOGY ECONOMICS
  • TABLE 150: JAPAN TECHNOLOGY MATURITY AND COMMERCIAL READINESS
  • TABLE 151: JAPAN COMPETITIVE AND CHANNEL STRUCTURE
  • TABLE 152: JAPAN GROWTH DRIVERS AND CONSTRAINTS
  • TABLE 153: INDIA MAMMOGRAPHY MARKET FORECAST BY REVENUE POOL, 2024A–2035F (USD MILLIONS)
  • TABLE 154: INDIA DEMAND AND SCREENING CONTEXT
  • TABLE 155: INDIA HEALTH-SYSTEM, REIMBURSEMENT, AND PROCUREMENT STRUCTURE
  • TABLE 156: INDIA INSTALLED BASE AND TECHNOLOGY ECONOMICS
  • TABLE 157: INDIA TECHNOLOGY MATURITY AND COMMERCIAL READINESS
  • TABLE 158: INDIA COMPETITIVE AND CHANNEL STRUCTURE
  • TABLE 159: INDIA GROWTH DRIVERS AND CONSTRAINTS
  • TABLE 160: SOUTH KOREA MAMMOGRAPHY MARKET FORECAST BY REVENUE POOL, 2024A–2035F (USD MILLIONS)
  • TABLE 161: SOUTH KOREA DEMAND AND SCREENING CONTEXT
  • TABLE 162: SOUTH KOREA HEALTH-SYSTEM, REIMBURSEMENT, AND PROCUREMENT STRUCTURE
  • TABLE 163: SOUTH KOREA INSTALLED BASE AND TECHNOLOGY ECONOMICS
  • TABLE 164: SOUTH KOREA TECHNOLOGY MATURITY AND COMMERCIAL READINESS
  • TABLE 165: SOUTH KOREA COMPETITIVE AND CHANNEL STRUCTURE
  • TABLE 166: SOUTH KOREA GROWTH DRIVERS AND CONSTRAINTS
  • TABLE 167: AUSTRALIA MAMMOGRAPHY MARKET FORECAST BY REVENUE POOL, 2024A–2035F (USD MILLIONS)
  • TABLE 168: AUSTRALIA DEMAND AND SCREENING CONTEXT
  • TABLE 169: AUSTRALIA HEALTH-SYSTEM, REIMBURSEMENT, AND PROCUREMENT STRUCTURE
  • TABLE 170: AUSTRALIA INSTALLED BASE AND TECHNOLOGY ECONOMICS
  • TABLE 171: AUSTRALIA TECHNOLOGY MATURITY AND COMMERCIAL READINESS
  • TABLE 172: AUSTRALIA COMPETITIVE AND CHANNEL STRUCTURE
  • TABLE 173: AUSTRALIA GROWTH DRIVERS AND CONSTRAINTS
  • TABLE 174: ROAPAC NAMED-CLUSTER FORECAST SUMMARY, 2024A–2035F (USD MILLIONS)
  • TABLE 175: ADVANCED ROAPAC MARKET STRUCTURE AND STRATEGIC READINESS
  • TABLE 176: ASEAN MARKET STRUCTURE AND STRATEGIC READINESS
  • TABLE 177: SOUTH ASIA EX-INDIA MARKET STRUCTURE AND STRATEGIC READINESS
  • TABLE 178: OTHER EMERGING APAC MARKET STRUCTURE AND STRATEGIC READINESS
  • ABLE 179: ROAPAC COMMERCIAL PLAYBOOK - WHAT EACH CLUSTER REWARDS
  • TABLE 180: LATIN AMERICA MAMMOGRAPHY MARKET FORECAST BY REVENUE POOL, 2024A–2035F (USD MILLIONS)
  • TABLE 181: LATAM DEMAND, SCREENING, AND POLICY CONTEXT
  • TABLE 182: LATAM HEALTH-SYSTEM, REIMBURSEMENT, AND PROCUREMENT STRUCTURE
  • TABLE 183: LATAM INSTALLED BASE AND UTILIZATION ECONOMICS
  • TABLE 184: LATAM TECHNOLOGY MATURITY AND COMMERCIAL READINESS
  • TABLE 185: LATAM COMPETITIVE AND CHANNEL STRUCTURE
  • TABLE 186: LATAM GROWTH DRIVERS AND CONSTRAINTS
  • TABLE 187: BRAZIL MAMMOGRAPHY MARKET FORECAST BY REVENUE POOL, 2024A–2035F (USD MILLIONS)
  • TABLE 188: BRAZIL DEMAND AND SCREENING CONTEXT
  • TABLE 189: BRAZIL HEALTH-SYSTEM, REIMBURSEMENT, AND PROCUREMENT STRUCTURE
  • TABLE 190: BRAZIL INSTALLED BASE AND TECHNOLOGY ECONOMICS
  • TABLE 191: BRAZIL TECHNOLOGY MATURITY AND COMMERCIAL READINESS
  • TABLE 192: BRAZIL COMPETITIVE AND CHANNEL STRUCTURE
  • TABLE 193: BRAZIL GROWTH DRIVERS AND CONSTRAINTS
  • TABLE 194: MEXICO MAMMOGRAPHY MARKET FORECAST BY REVENUE POOL, 2024A–2035F (USD MILLIONS)
  • TABLE 195: MEXICO DEMAND AND SCREENING CONTEXT
  • TABLE 196: MEXICO HEALTH-SYSTEM, REIMBURSEMENT, AND PROCUREMENT STRUCTURE
  • TABLE 197: MEXICO INSTALLED BASE AND TECHNOLOGY ECONOMICS
  • TABLE 198: MEXICO TECHNOLOGY MATURITY AND COMMERCIAL READINESS
  • TABLE 199: MEXICO COMPETITIVE AND CHANNEL STRUCTURE
  • TABLE 200: MEXICO GROWTH DRIVERS AND CONSTRAINTS
  • TABLE 201: REST OF LATAM MARKET FORECAST SUMMARY, 2024A–2035F (USD MILLIONS)
  • TABLE 202: REST OF LATAM MARKET STRUCTURE AND STRATEGIC READINESS
  • TABLE 203: MIDDLE EAST & AFRICA MAMMOGRAPHY MARKET FORECAST BY REVENUE POOL, 2024A–2035F (USD MILLIONS)
  • TABLE 204: MEA DEMAND, SCREENING, AND POLICY CONTEXT
  • TABLE 205: MEA HEALTH-SYSTEM, REIMBURSEMENT, AND PROCUREMENT STRUCTURE
  • TABLE 206: MEA INSTALLED BASE AND UTILIZATION ECONOMICS
  • TABLE 207: MEA TECHNOLOGY MATURITY AND COMMERCIAL READINESS
  • TABLE 208: MEA COMPETITIVE AND CHANNEL STRUCTURE
  • TABLE 209: MEA GROWTH DRIVERS AND CONSTRAINTS
  • TABLE 210: GCC MAMMOGRAPHY MARKET FORECAST SUMMARY, 2024A–2035F (USD MILLIONS)
  • TABLE 211: GCC MARKET STRUCTURE AND STRATEGIC READINESS
  • TABLE 212: SOUTH AFRICA MAMMOGRAPHY MARKET FORECAST BY REVENUE POOL, 2024A–2035F (USD MILLIONS)
  • TABLE 213: SOUTH AFRICA DEMAND AND SCREENING CONTEXT
  • TABLE 214: SOUTH AFRICA HEALTH-SYSTEM, REIMBURSEMENT, AND PROCUREMENT STRUCTURE
  • TABLE 215: SOUTH AFRICA INSTALLED BASE AND TECHNOLOGY ECONOMICS
  • TABLE 216: SOUTH AFRICA TECHNOLOGY MATURITY AND COMMERCIAL READINESS
  • TABLE 217: SOUTH AFRICA COMPETITIVE AND CHANNEL STRUCTURE
  • TABLE 218: SOUTH AFRICA GROWTH DRIVERS AND CONSTRAINTS
  • TABLE 219: REST OF MEA MARKET FORECAST SUMMARY, 2024A–2035F (USD MILLIONS)
  • TABLE 220: REST OF MEA MARKET STRUCTURE AND STRATEGIC READINESS